GlaxoSmithKline (GSK) and Innoviva (INVA) recently published promising data about the Salford Lung Study (SLS) in chronic obstructive pulmonary disease (COPD).
Articles by Timea Polgar
Therabron Therapeutics, a biotech company developing a novel class of drugs based on the naturally occurring secretoglobin proteins, announced a new…
Boehringer Ingelheim Pharmaceuticals, Inc., recently released data showing that Stiolto Respimat (inhalation spray) improved lung function over a range of measures…